CBLB and neoplasm: This knowledge has recently been used to improve the efficacy of adoptive T cell therapy by using cblb−/− T cells as cellular therapy, as this renders T cells resistant to inhibitory cues of the tumor microenvironment allowing improved cancer regression rates [24]–[27].